Yue Zhu Selected Research

San-Ao decoction

6/2020	[Effect of San'ao Decoction on ovalbum induced asthmatic mice and expression of TRPV2 in lung].
5/2019	Effect of San'ao decoction on aggravated asthma mice model induced by PM2.5 and TRPA1/TRPV1 expressions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yue Zhu Research Topics

Disease

57	Neoplasms (Cancer) 10/2022 - 01/2008
25	Inflammation (Inflammations) 06/2022 - 03/2009
13	Neoplasm Metastasis (Metastasis) 05/2022 - 03/2013
11	Osteoporosis 04/2022 - 01/2019
8	Carcinogenesis 01/2022 - 11/2017
8	Spinal Cord Injuries (Spinal Cord Injury) 07/2020 - 02/2005
7	Fibrosis (Cirrhosis) 06/2022 - 02/2018
7	Hypoxia (Hypoxemia) 12/2021 - 01/2018
6	Wounds and Injuries (Trauma) 10/2022 - 01/2008
6	Papillary Thyroid Cancer 04/2022 - 01/2017
6	Thyroid Neoplasms (Thyroid Cancer) 01/2022 - 10/2018
6	Postmenopausal Osteoporosis 01/2022 - 01/2019
5	Infections 10/2022 - 01/2018
5	Breast Neoplasms (Breast Cancer) 05/2022 - 12/2006
5	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 09/2018
5	Major Depressive Disorder (Major Depressive Disorders) 01/2021 - 02/2017
4	Compression Fractures (Compression Fracture) 07/2022 - 01/2019
4	Mitochondrial Diseases (Mitochondrial Disease) 03/2022 - 01/2018
4	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2016
4	Pain (Aches) 01/2022 - 04/2011
4	Arthritis (Polyarthritis) 01/2022 - 09/2015
4	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 04/2018
4	Experimental Arthritis 12/2021 - 06/2020
4	Squamous Cell Carcinoma of Head and Neck 01/2021 - 01/2020
4	Mental Disorders (Mental Disorder) 10/2020 - 12/2016
4	Scoliosis 05/2020 - 03/2011
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2019 - 01/2017
4	Intervertebral Disc Displacement (Herniated Disc) 01/2016 - 01/2008
3	Liver Cirrhosis (Hepatic Cirrhosis) 07/2022 - 01/2021
3	Non-alcoholic Fatty Liver Disease 06/2022 - 01/2016
3	Neuroinflammatory Diseases 01/2022 - 10/2019
3	Lung Neoplasms (Lung Cancer) 12/2021 - 01/2019
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2021 - 03/2018
3	Lymphatic Metastasis 10/2021 - 12/2006
3	Adenocarcinoma 10/2021 - 04/2013
3	Osteosarcoma (Osteogenic Sarcoma) 07/2021 - 01/2016
3	Carcinoma (Carcinomatosis) 03/2021 - 01/2019
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 02/2018
3	Schizophrenia (Dementia Praecox) 01/2021 - 01/2020
3	Dizziness (Lightheadedness) 10/2020 - 12/2016
3	Obesity 01/2020 - 10/2014
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2019 - 01/2018
2	Cardiotoxicity 03/2022 - 07/2021
2	Diarrhea 02/2022 - 03/2021
2	Necrosis 01/2022 - 08/2021
2	Colitis 01/2022 - 01/2021
2	Ulcerative Colitis 01/2022 - 01/2021
2	Colonic Neoplasms (Colon Cancer) 01/2022 - 01/2020
2	Cardiomyopathies (Cardiomyopathy) 01/2022 - 11/2021

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2007
13	Biomarkers (Surrogate Marker)IBA 05/2022 - 10/2010
13	Pharmaceutical PreparationsIBA 01/2022 - 09/2016
12	Therapeutic UsesIBA 01/2022 - 01/2020
11	MelatoninIBA 07/2022 - 03/2011
11	CytokinesIBA 01/2022 - 07/2009
10	Biological ProductsIBA 01/2022 - 10/2014
9	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 02/2002
8	LipidsIBA 01/2021 - 05/2013
7	Messenger RNA (mRNA)IBA 04/2022 - 12/2017
6	EnzymesIBA 01/2022 - 10/2010
6	Kai-Xin-SanIBA 01/2021 - 12/2016
5	AcidsIBA 01/2021 - 06/2018
5	Adenosine Triphosphate (ATP)IBA 01/2021 - 04/2011
4	CalciumIBA 01/2022 - 01/2018
4	AntioxidantsIBA 01/2022 - 03/2021
4	CollagenIBA 01/2022 - 01/2008
4	Blood Glucose (Blood Sugar)IBA 12/2021 - 01/2019
4	Ethanol (Ethyl Alcohol)IBA 03/2021 - 11/2016
4	Uric Acid (Urate)IBA 01/2021 - 01/2016
3	RNA (Ribonucleic Acid)IBA 05/2022 - 01/2020
3	Interleukin-17 (Interleukin 17)IBA 03/2022 - 01/2012
3	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2020
3	N-methyladenosineIBA 01/2022 - 01/2021
3	CateninsIBA 01/2022 - 01/2019
3	CadmiumIBA 01/2022 - 01/2021
3	UbiquitinIBA 01/2022 - 01/2021
3	Triglycerides (Triacylglycerol)IBA 12/2021 - 03/2020
3	Oncogene Proteins (Oncogene Protein)IBA 10/2021 - 03/2018
3	Long Noncoding RNAIBA 05/2021 - 05/2019
3	Indicators and Reagents (Reagents)IBA 01/2021 - 01/2017
3	Antidepressive Agents (Antidepressants)IBA 01/2021 - 02/2017
3	FrankincenseIBA 03/2020 - 09/2015
3	myrrh resin (myrrh)IBA 03/2020 - 09/2015
3	Aggrecans (Aggrecan)IBA 02/2015 - 01/2012
3	Complement System Proteins (Complement)IBA 10/2012 - 02/2005
2	NF-kappa B (NF-kB)IBA 07/2022 - 12/2021
2	Fatty Acids (Saturated Fatty Acids)IBA 06/2022 - 05/2013
2	AntigensIBA 04/2022 - 02/2019
2	6-methyladenineIBA 04/2022 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 03/2022 - 01/2021
2	Environmental Pollutants (Pollutants, Environmental)IBA 03/2022 - 02/2020
2	Phosphotransferases (Kinase)IBA 01/2022 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 11/2015
2	MethyltransferasesIBA 01/2022 - 01/2021

Therapy/Procedure

15	Therapeutics 01/2022 - 03/2009
10	Drug Therapy (Chemotherapy) 01/2021 - 02/2002
6	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 07/2009
6	Immunotherapy 01/2022 - 01/2019
4	Kyphoplasty 07/2022 - 01/2019
2	Radiotherapy 10/2022 - 04/2020